Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo
about
The Pro-inflammatory Effects of Glucocorticoids in the BrainEmerging role of HMGB1 in fibrotic diseasesThe immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cellsRAGE: a new frontier in chronic airways diseaseContemporary views on inflammatory pain mechanisms: TRPing over innate and microglial pathwaysTargeting HMGB1 in inflammationAmyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's diseaseAnimal models of sepsis and sepsis-induced kidney injuryGlycyrrhizin Protects Rats from Sepsis by Blocking HMGB1 SignalingThe receptor for advanced glycation end products (RAGE) and the lung.The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation.The anti-inflammatory activity of HMGB1 A box is enhanced when fused with C-terminal acidic tail.Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculatureHigh mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injuryHMGB1 contributes to glomerular endothelial cell injury in ANCA-associated vasculitis through enhancing endothelium-neutrophil interactionsMacrophage endocytosis of high-mobility group box 1 triggers pyroptosis.Pathophysiology and treatment of septic shock in neonates.TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]High-mobility group protein box-1 and its relevance to cerebral ischemiaInsulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humansHMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen.Insights into battles between Mycobacterium tuberculosis and macrophages.Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin.Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive declineHMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6C(high) inflammatory monocytes in murine sepsis survivors.High-mobility group box-1 induces proinflammatory cytokines production of Kupffer cells through TLRs-dependent signaling pathway after burn injuryGlycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in ratsHMGB1 in health and disease.HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signalingTLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant.Natural killer cells mediate severe liver injury in a murine model of halothane hepatitisStress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats: a priming stimulus of microglia and the NLRP3 inflammasome.Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli.Increased HMGB1 expression and release by mononuclear cells following surgical/anesthesia trauma.Antibiotic-induced imbalances in gut microbiota aggravates cholesterol accumulation and liver injuries in rats fed a high-cholesterol diet.
P2860
Q26742188-E6AD2491-D548-4FF2-BA20-5FCCA97232E4Q26828596-B2DF9E16-3F6A-4581-8B89-E69C1E86B5F5Q27022093-FE5CB7E1-DA77-4E4B-AAC5-9EB83AD57D3AQ27025295-025BB20B-1DA2-4357-99A8-C7FAFF0AD6A0Q28068037-922182B1-65DF-4425-8777-E9DC5B899CB5Q28266138-A25E172B-73B9-468C-AE87-EF3D4763481EQ28384947-B1B185BD-EEB4-4D71-BD40-C97711D42F95Q30490536-9F6375D4-7BB8-44E9-8375-D754499B83D1Q33624172-E398A9BB-8E00-4221-863A-E08D233EAF42Q33633330-D268B859-F8D5-443B-B46F-03E414BD854CQ33745462-20DA060E-ED4C-4EB6-9D22-9450F3A0600CQ33772017-5BE170F4-3007-4703-A717-174B40994CB8Q33814903-1BDD8683-702D-44C7-8568-9A1F991316C3Q33816455-A8527FA9-7EF2-4ED0-A749-1CF4AD735745Q33822512-EE7ABA73-75EA-4807-ACC6-4F35541826CEQ33836853-66D7D193-8C1B-40C8-8E4C-AC7898CA8513Q33840741-739A5872-BEE1-4F04-8090-DBB0D5F7B333Q33844590-F893E322-2172-4009-BF75-F482F4846E9DQ33858418-5ED26BFF-9CFE-4699-88D4-33877B7C61ADQ33940492-9D39422C-DE5B-4792-8DD3-F841DFD19CFCQ34000194-0EC1D5AA-7F48-4A81-A352-8DE011B97418Q34043446-03E43F46-6AD4-4BD9-A948-9E087986FA4EQ34170847-BBC67DB6-B571-4FA8-8A7D-EEE2B4D57AE0Q34237427-E9CC88AC-8C13-4335-A3FE-998B523408FBQ34238526-CDB73D9B-03F5-4B97-9BAF-917318445E6EQ34268873-A52AE8DE-9CA4-4B0B-AD40-1A03C47E41BFQ34310509-B3514A15-0D77-4354-817F-D9B870772800Q34377379-67F3CD4D-1225-4DEE-8E2B-0561A1E3D2EBQ34468465-B062A5D5-2701-4CA7-BF18-E68C435A6164Q34500594-C125F125-9F8D-4755-B78F-1EC788318133Q34591167-1A271BD2-EF22-4E7A-9973-BD8A4C4EF0E1Q34622835-67C9720E-7C34-427D-8547-EE8E14196902Q34627615-000E977C-1130-4D2C-AEB3-BA9A7748FB70Q34667534-0304057B-AE7C-441D-9615-A251E0EB3142Q34701790-544B0035-3CA6-47B8-9DA1-BD618284CFF9Q34869746-4E40E22A-E4A1-45A6-8A87-5C765F4709A5Q34958770-423C0A6B-9557-4CDF-84FD-A4CC6F08A4A7Q35170024-F0A7DA3A-578D-4892-8F92-AD3B283E171DQ35561332-FB5A99D3-32A8-4754-BD21-FB6418A236ADQ35679209-53A75815-8CA3-4DCD-AA3A-B336EA1513CC
P2860
Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Role of toll-like receptors 2 ...... 1-induced inflammation in vivo
@ast
Role of toll-like receptors 2 ...... 1-induced inflammation in vivo
@en
type
label
Role of toll-like receptors 2 ...... 1-induced inflammation in vivo
@ast
Role of toll-like receptors 2 ...... 1-induced inflammation in vivo
@en
prefLabel
Role of toll-like receptors 2 ...... 1-induced inflammation in vivo
@ast
Role of toll-like receptors 2 ...... 1-induced inflammation in vivo
@en
P2093
P2860
P1433
P1476
Role of toll-like receptors 2 ...... 1-induced inflammation in vivo
@en
P2093
Angelika Bierhaus
Bernd Arnold
Joost C M Meijers
Kevin J Tracey
Marieke A D van Zoelen
Peter P Nawroth
Shizuo Akira
P2860
P304
P356
10.1097/SHK.0B013E318186262D
P577
2009-03-01T00:00:00Z